title: The role of the neutral amino acid transporter SNAT2 in cell volume regulation.
abstract: Sodium-dependent neutral amino acid transporter-2 (SNAT2), the ubiquitous member of SLC38 family, accounts for the activity of transport system A for neutral amino acids in most mammalian tissues. As the transport process performed by SNAT2 is highly energized, system A substrates, such as glutamine, glycine, proline and alanine, reach high transmembrane gradients and constitute major components of the intracellular amino acid pool. Moreover, through a complex array of exchange fluxes, involving other amino acid transporters, and of metabolic reactions, such as the synthesis of glutamate from glutamine, SNAT2 activity influences the cell content of most amino acids, thus determining the overall size and the composition of the intracellular amino acid pool. As amino acids represent a large fraction of cell organic osmolytes, changes of SNAT2 activity are followed by modifications in both cell amino acids and cell volume. This mechanism is utilized by many cell types to perform an effective regulatory volume increase (RVI) upon hypertonic exposure. Under these conditions, the expression of SNAT2 gene is induced and newly synthesized SNAT2 proteins are preferentially targeted to the cell membrane, leading to a significant increase of system A transport Vmax. In cultured human fibroblasts incubated under hypertonic conditions, the specific silencing of SNAT2 expression, obtained with anti-SNAT2 siRNAs, prevents the increase in system A transport activity, hinders the expansion of intracellular amino acid pool, and significantly delays cell volume recovery. These results demonstrate the pivotal role played by SNAT2 induction in the short-term hypertonic RVI and suggest that neutral amino acids behave as compatible osmolytes in hypertonically stressed cells.
authors.affiliation: Unit of General and Clinical Pathology, Department of Experimental Medicine, University of Parma, Parma, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Franchi-Gazzola
authors.forename: V
authors.initials: V
authors.lastname: Dall'Asta
authors.forename: R
authors.initials: R
authors.lastname: Sala
authors.forename: R
authors.initials: R
authors.lastname: Visigalli
authors.forename: E
authors.initials: E
authors.lastname: Bevilacqua
authors.forename: F
authors.initials: F
authors.lastname: Gaccioli
authors.forename: G C
authors.initials: GC
authors.lastname: Gazzola
authors.forename: O
authors.initials: O
authors.lastname: Bussolati
mesh_terms: D000222:Adaptation, Physiological; D026924:Amino Acid Transport System A / Q000502:physiology*; D021542:Amino Acids, Neutral / Q000378:metabolism*; D001692:Biological Transport; D002462:Cell Membrane / Q000378:metabolism; D048429:Cell Size; D002478:Cells, Cultured; D005347:Fibroblasts / Q000378:metabolism; D005786:Gene Expression Regulation; D006801:Humans; D006982:Hypertonic Solutions; D034622:RNA Interference; D034741:RNA, Small Interfering; D014882:Water-Electrolyte Balance
chemical_list: D026924:Amino Acid Transport System A; D021542:Amino Acids, Neutral; D006982:Hypertonic Solutions; D034741:RNA, Small Interfering; C498797:SLC38A2 protein, human